Next Article in Journal
Immunogenicity of Tetravalent Protein Vaccine SCTV01E-2 against SARS-CoV-2 EG.5 Subvaraint: A Phase 2 Trial
Previous Article in Journal
Effectiveness of Influenza Vaccination and Early Antiviral Treatment in Reducing Pneumonia Risk in Severe Influenza Cases
 
 
Article

Article Versions Notes

Vaccines 2024, 12(2), 174; https://doi.org/10.3390/vaccines12020174
Action Date Notes Link
article xml file uploaded 8 February 2024 09:25 CET Original file -
article xml uploaded. 8 February 2024 09:25 CET Update https://www.mdpi.com/2076-393X/12/2/174/xml
article pdf uploaded. 8 February 2024 09:25 CET Version of Record https://www.mdpi.com/2076-393X/12/2/174/pdf
article supplementary file uploaded. 8 February 2024 09:25 CET - https://www.mdpi.com/2076-393X/12/2/174#supplementary
article html file updated 8 February 2024 09:27 CET Original file https://www.mdpi.com/2076-393X/12/2/174/html
Back to TopTop